Srinivas Vourganti to Epstein-Barr Virus Infections
This is a "connection" page, showing publications Srinivas Vourganti has written about Epstein-Barr Virus Infections.
Connection Strength
0.185
-
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. J Natl Cancer Inst. 2004 Oct 06; 96(19):1447-57.
Score: 0.063
-
Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Res. 2003 Mar 01; 63(5):965-71.
Score: 0.057
-
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder. J Clin Invest. 2001 Sep; 108(6):887-94.
Score: 0.051
-
Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration. Blood. 2002 Oct 01; 100(7):2341-8.
Score: 0.014